Sponsor or institution

Clinical trials and research at H. Lundbeck A/S

• 8Clinical trials
• 18Countries

Newest trials

All recruiting trials (8)

• Lu AH69593 in Healthy Adults

  This early-phase study tests how Lu AH69593 behaves in the body when given alone and with other medicines in healthy adults.

  Recruiting Phase 1 H. Lundbeck A/S · Madison, Wisconsin · NCT07775261

• Testing Lu AH69593 for safety and tolerance in healthy adults and people with narcolepsy

  This study tests whether Lu AH69593 is safe and well tolerated in adults, including those with narcolepsy, and looks at how the body processes the drug with and without food.

  Recruiting Phase 1 H. Lundbeck A/S · Helsinki and 1 other locations · NCT07613710

• Lu AF28996 addition for adults with Parkinson's and motor fluctuations

  This trial tests whether adding Lu AF28996 to optimized Parkinson's medications helps adults with motor fluctuations spend more time with controlled movement and less dyskinesia.

  Recruiting at 2 sites Phase 2 H. Lundbeck A/S · Farmington Hills, Michigan and 1 other locations · NCT07514858

• Lu AF28996 in people with Parkinson's disease

  This study tests whether Lu AF28996 is safe and tolerable for people with Parkinson's disease who have motor fluctuations.

  Recruiting at 4 sites Phase 1 H. Lundbeck A/S · Beijing, Beijing Municipality and 3 other locations · NCT07513441

• Eptinezumab for treating episodic migraine in children

  This study tests if a new medication called eptinezumab can help reduce the number of migraine days in children who have episodic migraines.

  Recruiting at 46 sites Phase 3 H. Lundbeck A/S · Stamford, Connecticut and 59 other locations · NCT05897320

• Evaluating Lu AG13909 for treating congenital adrenal hyperplasia

  This study is testing different doses of a new medication called Lu AG13909 to see if it can safely help adults with congenital adrenal hyperplasia manage their hormone levels better.

  Recruiting at 17 sites Phase 1/2 H. Lundbeck A/S · Ann Arbor, Michigan and 16 other locations · NCT05669950

• Long-term safety of eptinezumab for children and adolescents with migraines

  This study is testing the long-term safety of a migraine medication called eptinezumab in children and teens aged 6 to 17 who have chronic or episodic migraines.

  Recruiting at 54 sites Phase 3 H. Lundbeck A/S · New Haven, Connecticut and 63 other locations · NCT05164172

• Eptinezumab treatment for adolescents with chronic migraine

  This study is testing if a single infusion of eptinezumab can help reduce the number of migraine days for adolescents aged 12 to 17 who suffer from chronic migraines.

  Recruiting at 44 sites Phase 3 H. Lundbeck A/S · New Haven, Connecticut and 78 other locations · NCT04965675

Quick answers

How many clinical trials run by H. Lundbeck A/S are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 18 countries. The most sites are in United States (6 trials), Italy (4 trials), Poland (4 trials), United Kingdom (4 trials), Argentina (3 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 3, Phase 3: 3, Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →